Annovis Bio, Inc. (NYSE American:ANVS)

About the company

Annovis Bio, Inc. develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders. It offers posiphen compound for mild cognitive impairment and early stage Alzheimer's disease and bisnorcymserine compound that inhibits amyloid formation and prevents the progression of the Alzheimer's disease. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Berwyn, PA.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

2

CEO

Maria-Luisa Maccecchini

Exchange

NYSE American

Website

http://www.annovisbio.com

$NoneM

Total Revenue

2

Employees

$42.49M

Market Capitalization

-33.72

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 381445.74 82729.00 6.13 22.23 20.75
Merck & Co., Inc. MRK 196786.55 48081.00 7.39 19.42 21.10
Pfizer Inc. PFE 188747.85 50660.00 2.86 11.95 31.17
Eli Lilly & Co. LLY 151075.27 23087.00 51.27 26.63 23.97
AbbVie, Inc. ABBV 145342.96 34057.00 -23.26 17.33 24.65
Bristol Myers Squibb Co. BMY 108491.37 31006.00 2.63 92.24 3.08
Repligen Corp. RGEN 6389.28 286.00 6.13 278.40 8.11
Reata Pharmaceuticals, Inc. RETA 4839.72 20.00 22.93 -15.57 -150.30
Nektar Therapeutics NKTR 4363.04 137.00 3.41 -9.50 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3946.28 1.00 36.49 -6.04 None
Allakos, Inc. ALLK 3152.76 None 6.84 -33.71 None
ADC Therapeutics SA ADCT 2565.54 2.00 30.26 -22.00 None
Karuna Therapeutics, Inc. KRTX 2485.08 None 6.49 -61.27 None
OPKO Health, Inc. OPK 2448.18 891.00 1.74 -8.37 -32.92
Turning Point Therapeutics, Inc. TPTX 2259.72 None 6.80 -18.91 None
IGM Biosciences, Inc. IGMS 2221.15 None 9.79 -40.94 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Apellis Pharmaceuticals, Inc. APLS 2094.84 None 9.25 -5.02 None
Springworks Therapeutics, Inc. SWTX 1695.06 None 5.51 -27.19 None
Principia Biopharma, Inc. PRNB 1578.64 30.00 5.62 -22.46 -242.01
Y-mAbs Therapeutics, Inc. YMAB 1495.17 None 9.16 -16.23 None
Zymeworks, Inc. ZYME 1473.78 26.00 3.06 -8.69 -629.37
Tricida, Inc. TCDA 1300.46 None 6.69 -6.16 None
Akcea Therapeutics, Inc. AKCA 1289.13 341.00 2.65 -45.83 -8.59
Kiniksa Pharmaceuticals Ltd. KNSA 1267.20 None 6.56 -10.47 None
Akero Therapeutics, Inc. AKRO 1138.62 None 9.51 -22.44 None
Odonate Therapeutics, Inc. ODT 1127.52 None 9.24 -10.02 None
Arcutis Biotherapeutics, Inc. ARQT 1074.85 None 4.58 -17.19 None
Phibro Animal Health Corp. PAHC 1060.26 818.00 5.35 28.73 4.49
Athenex, Inc. ATNX 1014.78 123.00 6.22 -9.43 -87.86
Constellation Pharmaceuticals, Inc. CNST 932.16 None 4.39 -10.04 None
G1 Therapeutics, Inc. GTHX 811.30 1.00 3.51 -6.19 None
Gossamer Bio, Inc. GOSS 809.47 None 3.28 -4.07 None
Phathom Pharmaceuticals, Inc. PHAT 750.75 None 4.17 -2.76 None
Quanterix Corp. QTRX 742.50 60.00 6.55 -16.98 -71.52
Krystal Biotech, Inc. KRYS 721.31 None 4.21 -34.78 None
Oric Pharmaceuticals, Inc. ORIC 687.96 None -7.47 -22.75 None
Applied Therapeutics, Inc. APLT 686.84 14.00 4.43 -13.94 -19.41
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Aprea Therapeutics, Inc. APRE 647.22 None 5.73 -19.14 None
Arcturus Therapeutics Holdings, Inc. ARCT 632.06 19.00 58.58 -22.72 -151.34
Amneal Pharmaceuticals, Inc. AMRX 617.87 1679.00 4.25 -2.84 -11.85
Keros Therapeutics, Inc. KROS 601.74 8.00 -27.18 -28.33 -285.35
Oyster Point Pharma, Inc. OYST 546.00 None 5.49 -9.49 None
Mirum Pharmaceuticals, Inc. MIRM 491.75 None 3.20 -7.26 None
SIGA Technologies, Inc. SIGA 467.40 19.00 5.23 -23.75 -94.00
89bio, Inc. ETNB 457.80 None 5.65 -7.09 None
Fulcrum Therapeutics, Inc. FULC 444.13 1.00 7.48 -6.44 None
Osmotica Pharmaceuticals Plc OSMT 442.80 232.00 3.36 -1.61 -115.44
Biospecifics Technologies Corp. BSTC 442.54 40.00 3.59 18.93 61.80
Satsuma Pharmaceuticals, Inc. STSA 441.32 None 4.34 -12.13 None
Imara, Inc. IMRA 395.33 None 3.82 -11.23 None
DURECT Corp. DRRX 394.04 28.00 30.26 -16.30 -82.94
TCR2 Therapeutics, Inc. TCRR 383.04 None 2.62 -38.00 None
Kala Pharmaceuticals, Inc. KALA 383.04 6.00 4.19 -4.17 None
Relmada Therapeutics, Inc. RLMD 380.88 0.00 5.68 -31.82 -877.66
Crinetics Pharmaceuticals, Inc. CRNX 376.08 1.00 4.75 -6.45 -447.78
Ocular Therapeutix, Inc. OCUL 357.12 6.00 -43.76 -3.90 None
Ovid Therapeutics, Inc. OVID 349.65 None 8.27 -5.36 None
Aeglea Biotherapeutics, Inc. AGLE 303.27 4.00 9.57 -3.78 -523.27
Urovant Sciences Ltd. UROV 285.60 None -5.06 -1.98 None
IDEAYA Biosciences, Inc. IDYA 270.40 None 4.11 -6.20 None
Spero Therapeutics, Inc. SPRO 268.28 12.00 3.53 -3.30 -656.72
HOOKIPA Pharma, Inc. HOOK 267.80 13.00 2.42 -5.92 -333.02
Gritstone Oncology, Inc. GRTS 255.60 4.00 2.29 -2.45 None
AMAG Pharmaceuticals, Inc. AMAG 240.04 321.00 0.92 -0.65 -115.05
Lannett Co., Inc. LCI 234.84 542.00 0.80 -7.72 -5.77
KalVista Pharmaceuticals, Inc. KALV 224.64 12.00 2.48 -6.93 -263.38
Verrica Pharmaceuticals, Inc. VRCA 219.00 None 4.00 -7.18 None
Kaleido Biosciences, Inc. KLDO 207.90 None 7.37 -2.84 None
Sutro Biopharma, Inc. STRO 200.79 41.00 3.81 -3.29 -148.06
Veru, Inc. VERU 200.20 39.00 6.70 -20.53 -25.53
Galera Therapeutics, Inc. GRTX 187.25 None 3.50 -2.85 None
LogicBio Therapeutics, Inc. LOGC 175.03 1.00 5.28 -4.11 None
Protara Therapeutics, Inc. TARA 173.10 None 2.60 -11.23 None
Liquidia Technologies, Inc. LQDA 166.10 8.00 13.02 -3.37 -602.17
Avenue Therapeutics, Inc. ATXI 156.00 532.00 28.68 -10.71 26.69
Cyclerion Therapeutics, Inc. CYCN 153.49 6.00 1.93 -1.48 None
Corvus Pharmaceuticals, Inc. CRVS 147.45 None 2.36 -3.12 None
Lyra Therapeutics, Inc. LYRA 145.68 1.00 -1.24 -8.73 -491.16
Tyme Technologies, Inc. TYME 144.90 None 8.40 -6.63 None
scPharmaceuticals, Inc. SCPH 143.36 119.00 3.66 -4.57 -27.05
Evelo Biosciences, Inc. EVLO 140.80 None 5.18 -1.61 None
PhaseBio Pharmaceuticals, Inc. PHAS 134.85 2.00 2.50 -2.82 None
Mustang Bio, Inc. MBIO 125.60 None 2.93 -2.55 None
Aquestive Therapeutics, Inc. AQST 123.48 49.00 -7.11 -1.76 -139.64
Harrow Health, Inc. HROW 122.46 51.00 7.85 -4.96 -47.54
TFF Pharmaceuticals, Inc. TFFP 117.80 None 4.56 -3.04 None
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
NeuBase Therapeutics, Inc. NBSE 117.04 None 49.18 -2.62 None
Ayala Pharmaceuticals, Inc. AYLA 112.20 3.00 -2.64 -5.44 -679.19
Evolus, Inc. EOLS 100.50 45.00 1.80 -0.99 -217.51
Eton Pharmaceuticals, Inc. ETON 94.32 1.00 10.27 -4.72 None
Trevi Therapeutics, Inc. TRVI 93.60 None 1.98 -3.19 None
Milestone Pharmaceuticals, Inc. MIST 91.50 None 0.90 -1.47 None
EyePoint Pharmaceuticals, Inc. EYPT 78.49 26.00 5.54 -1.60 -196.30
Checkpoint Therapeutics, Inc. CKPT 76.80 2.00 6.62 -3.31 -949.53
Clearside Biomedical, Inc. CLSD 72.57 6.00 9.32 -4.12 -293.61
Xeris Pharmaceuticals, Inc. XERS 72.24 4.00 3.58 -0.56 None
Navidea Biopharmaceuticals, Inc. NAVB 68.17 1.00 -50.13 -6.17 -65.13
Baudax Bio, Inc. BXRX 63.54 None -1.73 -0.91 None
BiomX, Inc. PHGE 60.06 None 1.58 -1.40 None
Genprex, Inc. GNPX 59.60 None 5.06 -4.36 None
Assertio Therapeutics, Inc. ASRT 57.60 192.00 1.00 -0.35 -83.99
Aridis Pharmaceuticals, Inc. ARDS 55.44 1.00 -22.81 -1.90 -851.00
Aerpio Pharmaceuticals, Inc. ARPO 54.12 20.00 1.63 -2.87 -51.58
Menlo Therapeutics, Inc. MNLO 48.72 2.00 4.10 -0.52 -483.51
Eyenovia, Inc. EYEN 45.12 None 4.55 -2.20 None
Edesa Biotech, Inc. EDSA 44.01 0.00 6.27 -0.46 -395.23
Annovis Bio, Inc. ANVS 42.49 None 3.89 -33.72 None
Moleculin Biotech, Inc. MBRX 40.48 None 3.52 -4.40 None
Acer Therapeutics, Inc. ACER 36.30 3.00 2.65 -1.39 -274.69
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Citius Pharmaceuticals, Inc. CTXR 34.83 None 2.58 -2.02 None
AgeX Therapeutics, Inc. AGE 33.82 2.00 -44.50 -2.78 -658.11
Oncternal Therapeutics, Inc. ONCT 33.67 3.00 4.32 -1.34 -225.89
Mannatech, Inc. MTEX 33.40 156.00 1.41 7.52 3.45
Allena Pharmaceuticals, Inc. ALNA 33.35 None 4.39 -0.77 None
Aileron Therapeutics, Inc. ALRN 30.80 None 4.23 -1.16 None
Adamis Pharmaceuticals Corp. ADMP 30.16 22.00 1.16 -1.02 -140.33
CNS Pharmaceuticals, Inc. CNSP 29.28 None 5.08 -5.38 None
Hoth Therapeutics, Inc. HOTH 25.40 None 7.06 -2.82 None
Millendo Therapeutics, Inc. MLND 25.20 0.00 0.59 -0.54 None
Spring Bank Pharmaceuticals, Inc. SBPH 24.77 0.00 0.94 -0.95 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 19.76 1.00 8.67 -1.18 None
ProPhase Labs, Inc. PRPH 16.92 9.00 1.53 -5.64 -31.15
Adial Pharmaceuticals, Inc. ADIL 14.80 None 3.61 -1.95 None
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Novan, Inc. NOVN 14.38 5.00 -3.31 -0.46 -602.34
PDS Biotechnology Corp. PDSB 13.93 None 1.54 -0.55 None
Titan Pharmaceuticals, Inc. TTNP 12.07 4.00 5.03 -0.67 -437.91
Novus Therapeutics, Inc. NVUS 8.01 None 0.69 -0.38 None
Brickell Biotech, Inc. BBI 4.68 5.00 1.53 -0.06 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

BRIEF-Annovis Bio Receives Institutional Review Board Approval To Initiate Phase 2 Study In 68 Parkinson’s And Alzheimer’s Patients

3d ago, source: Reuters

ANNOVIS BIO RECEIVES INSTITUTIONAL REVIEW BOARD APPROVAL TO INITIATE 15 SITE PHASE 2 STUDY IN 68 PARKINSON’S AND ALZHEIMER’S PATIENTS * ANNOVIS BIO INC - REMAIN ON TRACK TO COMPLETE STUDY BY Q1 OF ...

58 Biggest Movers From Yesterday

7h ago, source: Benzinga on MSN.com

Team, Inc. (NYSE: TISI) fell 13.6% to close at $4.21. AZZ Inc. (NYSE: AZZ) dipped 13.5% to close at $28.61 after the company reported a significant decline in Q1 earnings. Annovis Bio, Inc. (NYSE: ...

ANVS Annovis Bio, Inc. Common Stock

8d ago, source: Nasdaq

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

Annovis Bio on go to launch mid-stage study of lead drug in Alzheimer's and Parkinson's

3d ago, source: Seeking Alpha

Thinly traded nano cap (NYSEMKT:ANVS) rockets 100% premarket on increased volume in reaction to its announcement of Institutional Review Board (IRB) signoff for a 15-site Phase 2 clinical trial ...

Annovis Bio off highs on lead drug advancement-stoked rally

2d ago, source: Seeking Alpha

Thinly traded nano cap Annovis Bio (ANVS +77.3%) jumps on a whopping 506x surge in volume in reaction to its announcement that it has secured IRB approval to proceed with a 15-site clinical trial ...

Stock Alert: Annovis Bio Shares Rocket 122% In Premarket

3d ago, source: Business Insider

Disclaimer | Commerce Policy | Made In NYC | Stock quotes by finanzen.net (RTTNews) - Shares of Annovis Bio Inc. (ANVS) are surging over 122% in pre-market today, after the company announced that ...

CRVS, HEPA Jump On COVID-19 Drug Bandwagon, LVGO In Good Health, NVAX Joins $100 Stock Price Club

2d ago, source: Nasdaq

Read on… 1. Annovis To Advance ANVS401 Into Parkinson's/ Alzheimer's Study Annovis Bio Inc. (ANVS) has received clearance from the Central Institutional Review Board to begin a phase II study of its ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.